End-of-day quote
Korea S.E.
23:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
67,400
KRW
|
+10.49%
|
|
+18.04%
|
+51.97%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
806,802
|
1,422,311
|
931,838
|
714,891
|
491,746
|
916,342
|
Enterprise Value (EV)
1 |
743,165
|
1,228,383
|
1,003,006
|
811,591
|
670,775
|
1,098,221
|
P/E ratio
|
8.1
x
|
12.1
x
|
0.42
x
|
22.7
x
|
7.66
x
|
10.1
x
|
Yield
|
1.58%
|
1.01%
|
-
|
0.43%
|
0.71%
|
-
|
Capitalization / Revenue
|
0.84
x
|
1.39
x
|
3.95
x
|
1.71
x
|
0.87
x
|
1.39
x
|
EV / Revenue
|
0.77
x
|
1.2
x
|
4.25
x
|
1.95
x
|
1.19
x
|
1.66
x
|
EV / EBITDA
|
3.54
x
|
5.45
x
|
18.2
x
|
9.9
x
|
6.68
x
|
6.72
x
|
EV / FCF
|
30.5
x
|
11.8
x
|
-4.73
x
|
41.2
x
|
-23.2
x
|
-91.9
x
|
FCF Yield
|
3.28%
|
8.49%
|
-21.1%
|
2.43%
|
-4.31%
|
-1.09%
|
Price to Book
|
1.11
x
|
1.71
x
|
0.9
x
|
0.66
x
|
0.43
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
9,382
|
9,329
|
20,662
|
20,662
|
20,662
|
20,662
|
Reference price
2 |
85,999
|
152,466
|
45,100
|
34,600
|
23,800
|
44,350
|
Announcement Date
|
18/03/19
|
16/03/20
|
19/03/21
|
21/03/22
|
21/03/23
|
18/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
963,425
|
1,021,272
|
235,745
|
417,195
|
565,106
|
661,555
|
EBITDA
1 |
210,024
|
225,230
|
55,066
|
82,007
|
100,452
|
163,351
|
EBIT
1 |
161,430
|
173,134
|
16,576
|
54,442
|
67,497
|
125,974
|
Operating Margin
|
16.76%
|
16.95%
|
7.03%
|
13.05%
|
11.94%
|
19.04%
|
Earnings before Tax (EBT)
1 |
146,637
|
171,758
|
68,899
|
49,710
|
64,611
|
103,017
|
Net income
1 |
99,549
|
117,219
|
1,442,659
|
31,458
|
64,189
|
91,028
|
Net margin
|
10.33%
|
11.48%
|
611.96%
|
7.54%
|
11.36%
|
13.76%
|
EPS
2 |
10,621
|
12,565
|
106,556
|
1,523
|
3,107
|
4,406
|
Free Cash Flow
1 |
24,354
|
104,328
|
-211,846
|
19,689
|
-28,921
|
-11,949
|
FCF margin
|
2.53%
|
10.22%
|
-89.86%
|
4.72%
|
-5.12%
|
-1.81%
|
FCF Conversion (EBITDA)
|
11.6%
|
46.32%
|
-
|
24.01%
|
-
|
-
|
FCF Conversion (Net income)
|
24.46%
|
89%
|
-
|
62.59%
|
-
|
-
|
Dividend per Share
2 |
1,356
|
1,537
|
-
|
150.0
|
170.0
|
-
|
Announcement Date
|
18/03/19
|
16/03/20
|
19/03/21
|
21/03/22
|
21/03/23
|
18/03/24
|
Fiscal Period: December |
2023 Q3
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
23.4
|
Net margin
|
-
|
EPS
2 |
1,133
|
Dividend per Share
|
-
|
Announcement Date
|
14/11/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
71,168
|
96,700
|
179,029
|
181,880
|
Net Cash position
1 |
63,637
|
193,928
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.292
x
|
1.179
x
|
1.782
x
|
1.113
x
|
Free Cash Flow
1 |
24,354
|
104,328
|
-211,846
|
19,689
|
-28,921
|
-11,949
|
ROE (net income / shareholders' equity)
|
14.9%
|
15.1%
|
6%
|
2.8%
|
5.21%
|
6.82%
|
ROA (Net income/ Total Assets)
|
10.6%
|
9.99%
|
0.83%
|
2.38%
|
2.63%
|
4.53%
|
Assets
1 |
938,361
|
1,172,949
|
174,003,041
|
1,323,449
|
2,444,289
|
2,008,379
|
Book Value Per Share
2 |
77,772
|
89,111
|
50,120
|
52,436
|
55,592
|
59,901
|
Cash Flow per Share
2 |
19,709
|
37,128
|
5,273
|
7,443
|
4,960
|
6,004
|
Capex
1 |
81,631
|
102,003
|
280,671
|
22,640
|
43,579
|
131,925
|
Capex / Sales
|
8.47%
|
9.99%
|
119.06%
|
5.43%
|
7.71%
|
19.94%
|
Announcement Date
|
18/03/19
|
16/03/20
|
19/03/21
|
21/03/22
|
21/03/23
|
18/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +51.97% | 1.03B | | +15.43% | 65.38B | | -0.22% | 47.8B | | +15.30% | 40.65B | | +23.50% | 26.69B | | +10.57% | 19.24B | | +2.39% | 17.75B | | -21.87% | 16B | | +3.02% | 15.23B | | -9.48% | 15.37B |
Other Specialty Chemicals
|